Hospital
Steward NSMC, INC.
Steward NSMC, INC. was paid $5.76M by Medicaid between Jul 2021 and Dec 2024, across 162 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.
33Billing provider infoSTEWARD NSMC, INC.
MIAMI, FL 33150
MIAMI, FL 33150
33aNPI1598337305assigned 07/12/2021
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.76M
24GClaims161,486
24DCodes billed162
24AFirst – last monthJul 2021 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#77 of 163
Median peer was paid$4.77M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 41,307 | $2.17M | |
| 2022 | 72,342 | $1.93M | |
| 2023 | 34,376 | $1.15M | |
| 2024incomplete | 13,461 | $507K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 10,180 | 8,769 | $1.58M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 9,769 | 8,233 | $1.16M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 5,225 | 4,306 | $759K |
| 70450 | Computed tomography, head or brain; without contrast material | 11% | 1,256 | 1,113 | $657K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 10% | 866 | 752 | $604K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.6% | 356 | 324 | $264K |
| G0378 | Hospital observation service, per hour | 2.0% | 4,281 | 1,987 | $117K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 1,107 | 950 | $117K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 194 | 149 | $104K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 77 | 67 | $49K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 460 | 382 | $37K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,716 | 1,304 | $34K |
150 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 870 | $27K |
| 80053 | Comprehensive metabolic panel | <1% | 7,769 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,445 | $14K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 711 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 616 | $13K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 366 | $12K |
| 71250 | <1% | 88 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 507 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 124 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,394 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 469 | $8K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,696 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,846 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 946 | $8K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,864 | $7K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 750 | $7K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 267 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,802 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 235 | $6K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,930 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,648 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,064 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 277 | $4K |
| 81001 | <1% | 4,853 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 261 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 182 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,732 | $3K |
| 59025 | Fetal non-stress test | <1% | 102 | $3K |
| 93970 | <1% | 79 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 301 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 935 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,955 | $2K |
| 81025 | <1% | 3,927 | $2K | |
| 96376 | <1% | 808 | $2K | |
| 76801 | <1% | 641 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,451 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,929 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 511 | $1K |
| 74022 | <1% | 28 | $1K | |
| 73630 | <1% | 264 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 93 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 311 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 97 | $1K |
| 73562 | <1% | 247 | $1K | |
| 97162 | <1% | 62 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,341 | $1K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 267 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,035 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,636 | $988.15 |
| 72100 | <1% | 202 | $755.93 | |
| 93971 | <1% | 18 | $700.35 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 808 | $681.54 |
| 84484 | <1% | 3,441 | $576.31 | |
| 84702 | <1% | 1,084 | $565.35 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 191 | $555.13 |
| 73610 | <1% | 194 | $546.69 | |
| 85730 | <1% | 3,003 | $528.83 | |
| 87070 | <1% | 381 | $513.76 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 205 | $510.35 |
| 85610 | <1% | 3,340 | $487.30 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 47 | $459.83 |
| 73502 | <1% | 34 | $450.67 | |
| 76641 | <1% | 22 | $394.40 | |
| 83735 | <1% | 1,754 | $382.36 | |
| 84703 | <1% | 707 | $381.18 | |
| 83690 | <1% | 2,216 | $364.22 | |
| 73590 | <1% | 32 | $344.78 | |
| 72131 | <1% | 14 | $339.54 | |
| 73130 | <1% | 121 | $336.83 | |
| 73030 | <1% | 200 | $307.32 | |
| 81003 | <1% | 217 | $292.15 | |
| 87076 | <1% | 448 | $259.53 | |
| 84100 | <1% | 733 | $211.86 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 316 | $191.60 |
| 85045 | <1% | 33 | $178.62 | |
| A9270 | Non-covered item or service | <1% | 283 | $162.00 |
| 97116 | <1% | 285 | $156.78 | |
| 82550 | <1% | 1,353 | $156.46 | |
| 83880 | <1% | 1,247 | $149.71 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 638 | $128.92 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 976 | $124.21 |
| 12011 | <1% | 12 | $120.06 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,306 | $119.38 |
| S0028 | Injection, famotidine, 20 mg | <1% | 368 | $110.31 |
| 85379 | <1% | 636 | $109.62 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 522 | $106.36 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 330 | $94.58 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 304 | $90.00 |
| 80061 | Lipid panel | <1% | 224 | $90.00 |
| 87186 | <1% | 487 | $89.71 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,678 | $83.90 |
| 86850 | <1% | 793 | $70.58 | |
| 73110 | <1% | 47 | $57.92 | |
| 74018 | <1% | 18 | $40.98 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 52 | $37.50 |
| 86592 | <1% | 136 | $20.16 | |
| 86901 | <1% | 848 | $18.28 | |
| 86900 | <1% | 847 | $18.28 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 320 | $16.67 |
| 82962 | <1% | 1,663 | $14.99 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 141 | $11.70 |
| 85007 | <1% | 296 | $8.01 | |
| 86140 | <1% | 416 | $6.33 | |
| 85027 | <1% | 287 | $6.26 | |
| 83605 | <1% | 364 | $4.21 | |
| 87040 | <1% | 469 | $4.21 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 198 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 470 | $0.00 |
| 82728 | 0% | 132 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 211 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 428 | $0.00 |
| 87205 | 0% | 154 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 351 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 23 | $0.00 |
| 87430 | 0% | 210 | $0.00 | |
| 94760 | 0% | 72 | $0.00 | |
| 83615 | 0% | 88 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 394 | $0.00 |
| 72170 | 0% | 30 | $0.00 | |
| 86738 | 0% | 32 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 45 | $0.00 |
| 87340 | 0% | 112 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 355 | $0.00 |
| 87449 | 0% | 74 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 61 | $0.00 |
| 82150 | 0% | 138 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 76 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 34 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 81 | $0.00 |
| 97166 | 0% | 17 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 32 | $0.00 |
| 82607 | 0% | 35 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 12 | $0.00 |
| 85651 | 0% | 12 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 16 | $0.00 |
| 84439 | 0% | 152 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 118 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 778 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 82 | $0.00 |
| 87185 | 0% | 13 | $0.00 | |
| 85384 | 0% | 142 | $0.00 | |
| 87210 | 0% | 77 | $0.00 | |
| 90714 | 0% | 56 | $0.00 | |
| 87899 | 0% | 61 | $0.00 | |
| 84145 | 0% | 412 | $0.00 | |
| 80076 | 0% | 274 | $0.00 | |
| 84550 | 0% | 20 | $0.00 | |
| 86703 | 0% | 49 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 20 | $0.00 |
| 94664 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLTZ, HERBERT (OFFICER, DIRECTOR, GENERAL COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Steward PGH, INC. | Hialeah, FL | $5.50M |
| Steward HH. INC. | Hialeah, FL | $5.16M |
| Steward NSMC, INC. | Lauderdale Lakes, FL | $3.53M |
| Steward CGH, INC. | Coral Gables, FL | $2.40M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.